When is non‑invasive prenatal testing (NIPT) indicated, and what are the recommended next steps for low‑risk and high‑risk results?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 2, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Non-Invasive Prenatal Testing (NIPT): Indications and Management

NIPT should be offered to ALL pregnant patients with singleton or twin gestations as the preferred screening method for fetal trisomies 21,18, and 13, regardless of maternal age or risk status. 1

Who Should Receive NIPT

Universal Offering

  • All pregnant patients should be made aware of NIPT availability and have access to pre- and post-test counseling 1
  • NIPT can be performed any time during gestation, though typically after 10 weeks 1
  • Both singleton and twin pregnancies are appropriate candidates 1

Performance Characteristics

For Singleton Pregnancies:

  • Trisomy 21: 98.8% detection rate, 0.04% false-positive rate, 91.8% PPV 1
  • Trisomy 18: 98.83% detection rate, 0.07% false-positive rate, 65.8% PPV 1
  • Trisomy 13: 92.85% detection rate, 0.04% false-positive rate, 37.2% PPV 1

For Twin Pregnancies:

  • Trisomy 21: 98.2% sensitivity, 99.9% specificity 1
  • Performance equivalent to singletons for common trisomies 1

Relative Contraindications

Do not perform NIPT in these situations:

  • Known vanishing twin gestation (accuracy may be impacted; counsel patient if proceeding) 1
  • Known maternal malignancy (somatic genomic aberrations interfere with interpretation) 1

Management of NIPT Results

Low-Risk (Negative) Results

Routine prenatal care with standard ultrasound monitoring 2

Critical caveat: Even with low-risk NIPT results, remain vigilant for abnormal ultrasound findings in the second and third trimesters. In one study, 39.4% of twin pregnancies with low-risk NIPT had subsequent abnormal ultrasound findings, and prenatal diagnosis was indicated in 16.7% 2. Do not let a negative NIPT result create false reassurance if structural abnormalities appear on ultrasound.

High-Risk (Positive) Results

All positive NIPT results MUST be confirmed with invasive diagnostic testing (amniocentesis or CVS) before making irreversible pregnancy decisions 1, 3

Why confirmation is essential:

  • NIPT is a screening test, not a diagnostic test 3, 4
  • PPV varies significantly by condition:
    • T21: 91.8% (meaning ~8% are false positives) 1
    • T18: 65.8% (meaning ~34% are false positives) 1
    • T13: 37.2% (meaning ~63% are false positives) 1
    • Sex chromosome aneuploidies: 29.5%-41% overall PPV 1, 4

Management algorithm for positive results:

  1. Provide genetic counseling immediately
  2. Offer invasive diagnostic testing (amniocentesis preferred after 15 weeks)
  3. Perform karyotype analysis or chromosomal microarray on amniotic fluid
  4. Make pregnancy management decisions only after diagnostic confirmation

Sex Chromosome Aneuploidy (SCA) Screening

NIPT can be offered for SCA screening in singleton pregnancies 1

Performance characteristics:

  • Overall detection rate: 99.6% 1
  • Specificity: 99.8% 1
  • However, PPV is significantly lower than for autosomal trisomies (29.5% for monosomy X, up to 75% for XYY) 1, 4

For twin pregnancies: SCA screening performance requires further evaluation before routine recommendation 2

Copy Number Variants (CNV) and Other Aneuploidies

NIPT for CNV detection has limited clinical utility:

  • PPV only 32.14% 4
  • False-positive rate 0.15% 4

NIPT is NOT recommended for screening other chromosomal aneuploidies (e.g., trisomy 2,9,16) with only 12.5% PPV 4

Common Pitfalls to Avoid

  1. Never present NIPT as diagnostic testing - 13% of providers incorrectly offered it as diagnostic in one survey 3
  2. Always confirm positive results - approximately 65% of patients undergo confirmatory testing, but this should be 100% 3
  3. Don't ignore ultrasound findings - abnormal anatomy scan findings require diagnostic testing regardless of NIPT results 2
  4. Understand PPV limitations - lower prevalence conditions (T13, T18, SCA) have substantially lower PPV than T21 1, 4
  5. Counsel about test limitations - NIPT does not detect all chromosomal abnormalities or structural defects 1

References

Related Questions

Should a pregnant patient's refusal of non‑invasive prenatal testing (NIPT) be documented in the medical record?
At what gestational age should Non-Invasive Prenatal Testing (NIPT) be completed based on British Columbia, Canada recommendations?
What is the percentage likelihood that the baby is completely normal and the percentages for each possible outcome (low‑risk, atypical, high‑risk) of the second non‑invasive prenatal test (NIPT) in a 28‑year‑old woman (29 at delivery) carrying a male fetus with a first‑trimester nuchal translucency of 2 mm, a normal 16‑week anatomy scan, a present nasal bone, and an initial NIPT reported as atypical involving chromosome 21 without PPV or fetal‑fraction data?
Is a Papanicolaou test safe at 7 weeks gestation?
If 100 mL of normal saline is to be infused over 25 minutes and 1 mL equals 20 drops, what is the drop rate per minute?
Why does thyroid-stimulating hormone (TSH) spike and then return to normal on repeat testing?
Which suture types (absorbable monofilament, absorbable braided, non‑absorbable monofilament, non‑absorbable braided) are recommended for deep fascial/subcutaneous closure, skin closure, and for patients allergic to nylon or silk?
What temperature should the rotavirus vaccine be stored at, and how long can it be used after removal from the refrigerator?
In a patient newly diagnosed with invasive ductal carcinoma of the breast, what is the purpose of the next-step targeted breast and axillary ultrasound?
Is it safe to combine buspirone (BuSpar) with doxepin?
How is the Candida score calculated and what antifungal therapy is recommended based on the score?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.